From: Investigation on urinary and serum alpha klotho in dogs with chronic kidney disease
Laboratory Variable | Control (n = 10) | All CKD (n = 27) | Stage 1 (n = 8) | Stage 2 (n = 8) | Stage 3 (n = 7) | Stage 4 (n = 4) |
---|---|---|---|---|---|---|
UrKl/Cr (pg/gCr) | 13.16 (5.75–34.84) | 5.85 (0.08–82.28) | 12.32 (3.03–82.28) | 13.57 (2.15-18.00) | 0.81 (0.30–4.37) | 3.98 (0.08–5.85) |
Serum Klotho (pg/mL) | 132.25 (57.46-169.33) | 59.13 (0.47-189.13) | 78.32 (10.47-122.47) | 30.14 (0.47–72.47) | 19.8 (2.47–70.47) | 127.47 (77.13-189.13) |
SDMA (µg/dL) | 8 (5–13) | 28 (8–74) | 13.5 (8–17) | 22.5 (18–31) | 37 (34–47) | 58.5 (52–74) |
Creatinine (mg/dL) | 0.8 (0.6-1) | 1.9 (0.7–11.1) | 1.1 (0.7–1.3) | 1.75 (1.5–2.3) | 3 (1.8–4.2) | 5 (3.8–11.1) |
BUN (mg/dL) | 21.4 (9-33.8) | 55.7 (6.8-167.7) | 25.05 (6.8–47.5) | 51.25 (19-108.2) | 89 (43.4-111.8) | 135.6 (76.7-167.7) |
Phosphorus (mg/dL) | 3.7 (3.1–5.2) | 3.9 (2.9–19) | 3.3 (2.9–3.8) | 4 (2.9–5.3) | 5.9 (3.1–8.38) | 11.15 (4.39-19) |